Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Clinical trial NCT04823091 · UNKNOWN

Trial details

NCT number: NCT04823091
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T-Cell Lymphocytic Leukemia T-Cell Chronic Lymphocytic Leukemia T Cell Non-Hodgkin Lymphoma

Start date: 2021-04-15
Primary completion: 2023-04-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.